105 related articles for article (PubMed ID: 18316625)
61. Metformin improves defective hematopoiesis and delays tumor formation in Fanconi anemia mice.
Zhang QS; Tang W; Deater M; Phan N; Marcogliese AN; Li H; Al-Dhalimy M; Major A; Olson S; Monnat RJ; Grompe M
Blood; 2016 Dec; 128(24):2774-2784. PubMed ID: 27756748
[TBL] [Abstract][Full Text] [Related]
62. The Sirt1 activator SRT3025 expands hematopoietic stem and progenitor cells and improves hematopoiesis in Fanconi anemia mice.
Zhang QS; Deater M; Schubert K; Marquez-Loza L; Pelz C; Sinclair DA; Grompe M
Stem Cell Res; 2015 Jul; 15(1):130-40. PubMed ID: 26046330
[TBL] [Abstract][Full Text] [Related]
63. What is wrong with Fanconi anemia cells?
Cantor SB; Brosh RM
Cell Cycle; 2014; 13(24):3823-7. PubMed ID: 25486020
[TBL] [Abstract][Full Text] [Related]
64. Systemic DNA damage accumulation under in vivo tumor growth can be inhibited by the antioxidant Tempol.
Georgakilas AG; Redon CE; Ferguson NF; Kryston TB; Parekh P; Dickey JS; Nakamura AJ; Mitchell JB; Bonner WM; Martin OA
Cancer Lett; 2014 Oct; 353(2):248-57. PubMed ID: 25069035
[TBL] [Abstract][Full Text] [Related]
65. Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs.
Liu GH; Suzuki K; Li M; Qu J; Montserrat N; Tarantino C; Gu Y; Yi F; Xu X; Zhang W; Ruiz S; Plongthongkum N; Zhang K; Masuda S; Nivet E; Tsunekawa Y; Soligalla RD; Goebl A; Aizawa E; Kim NY; Kim J; Dubova I; Li Y; Ren R; Benner C; Del Sol A; Bueren J; Trujillo JP; Surralles J; Cappelli E; Dufour C; Esteban CR; Belmonte JCI
Nat Commun; 2014 Jul; 5():4330. PubMed ID: 24999918
[TBL] [Abstract][Full Text] [Related]
66. Oxidative stress-associated protein tyrosine kinases and phosphatases in Fanconi anemia.
Li J; Pang Q
Antioxid Redox Signal; 2014 May; 20(14):2290-301. PubMed ID: 24206276
[TBL] [Abstract][Full Text] [Related]
67. Evaluation of resveratrol and N-acetylcysteine for cancer chemoprevention in a Fanconi anemia murine model.
Zhang QS; Marquez-Loza L; Sheehan AM; Watanabe-Smith K; Eaton L; Benedetti E; Major A; Schubert K; Deater M; Joseph E; Grompe M
Pediatr Blood Cancer; 2014 Apr; 61(4):740-2. PubMed ID: 24115584
[TBL] [Abstract][Full Text] [Related]
68. Fancd2 and p21 function independently in maintaining the size of hematopoietic stem and progenitor cell pool in mice.
Zhang QS; Watanabe-Smith K; Schubert K; Major A; Sheehan AM; Marquez-Loza L; Newell AE; Benedetti E; Joseph E; Olson S; Grompe M
Stem Cell Res; 2013 Sep; 11(2):687-92. PubMed ID: 23721813
[TBL] [Abstract][Full Text] [Related]
69. Learning from a paradox: recent insights into Fanconi anaemia through studying mouse models.
Bakker ST; de Winter JP; te Riele H
Dis Model Mech; 2013 Jan; 6(1):40-7. PubMed ID: 23268537
[TBL] [Abstract][Full Text] [Related]
70. Molecular pathogenesis and clinical management of Fanconi anemia.
Kee Y; D'Andrea AD
J Clin Invest; 2012 Nov; 122(11):3799-806. PubMed ID: 23114602
[TBL] [Abstract][Full Text] [Related]
71. The antioxidant tempol reduces carcinogenesis and enhances survival in mice when administered after nonlethal total body radiation.
Mitchell JB; Anver MR; Sowers AL; Rosenberg PS; Figueroa M; Thetford A; Krishna MC; Albert PS; Cook JA
Cancer Res; 2012 Sep; 72(18):4846-55. PubMed ID: 22805306
[TBL] [Abstract][Full Text] [Related]
72. Strategies for discovery of small molecule radiation protectors and radiation mitigators.
Greenberger JS; Clump D; Kagan V; Bayir H; Lazo JS; Wipf P; Li S; Gao X; Epperly MW
Front Oncol; 2011; 1():59. PubMed ID: 22655254
[TBL] [Abstract][Full Text] [Related]
73. Improvement of genetic stability in lymphocytes from Fanconi anemia patients through the combined effect of α-lipoic acid and N-acetylcysteine.
Ponte F; Sousa R; Fernandes AP; Gonçalves C; Barbot J; Carvalho F; Porto B
Orphanet J Rare Dis; 2012 May; 7():28. PubMed ID: 22591656
[TBL] [Abstract][Full Text] [Related]
74. SOD mimetics: a novel class of androgen receptor inhibitors that suppresses castration-resistant growth of prostate cancer.
Thomas R; Sharifi N
Mol Cancer Ther; 2012 Jan; 11(1):87-97. PubMed ID: 22172488
[TBL] [Abstract][Full Text] [Related]
75. GS-nitroxide (JP4-039)-mediated radioprotection of human Fanconi anemia cell lines.
Bernard ME; Kim H; Berhane H; Epperly MW; Franicola D; Zhang X; Houghton F; Shields D; Wang H; Bakkenist CJ; Frantz MC; Forbeck EM; Goff JP; Wipf P; Greenberger JS
Radiat Res; 2011 Nov; 176(5):603-12. PubMed ID: 21939290
[TBL] [Abstract][Full Text] [Related]
76. Nitroxide derivatives of non-steroidal anti-inflammatory drugs exert anti-inflammatory and superoxide dismutase scavenging properties in A459 cells.
Flores-Santana W; Moody T; Chen W; Gorczynski MJ; Shoman ME; Velázquez C; Thetford A; Mitchell JB; Cherukuri MK; King SB; Wink DA
Br J Pharmacol; 2012 Feb; 165(4b):1058-67. PubMed ID: 21658022
[TBL] [Abstract][Full Text] [Related]
77. Fancd2-/- mice have hematopoietic defects that can be partially corrected by resveratrol.
Zhang QS; Marquez-Loza L; Eaton L; Duncan AW; Goldman DC; Anur P; Watanabe-Smith K; Rathbun RK; Fleming WH; Bagby GC; Grompe M
Blood; 2010 Dec; 116(24):5140-8. PubMed ID: 20826722
[TBL] [Abstract][Full Text] [Related]
78. Redox-dependent Brca1 transcriptional regulation by an NADH-sensor CtBP1.
Deng Y; Liu J; Han G; Lu SL; Wang SY; Malkoski S; Tan AC; Deng C; Wang XJ; Zhang Q
Oncogene; 2010 Dec; 29(50):6603-8. PubMed ID: 20818429
[TBL] [Abstract][Full Text] [Related]
79. Susceptibility pathways in Fanconi's anemia and breast cancer.
D'Andrea AD
N Engl J Med; 2010 May; 362(20):1909-19. PubMed ID: 20484397
[TBL] [Abstract][Full Text] [Related]
80. Significance of the Fanconi anemia FANCD2 protein in sporadic and metastatic human breast cancer.
Rudland PS; Platt-Higgins AM; Davies LM; de Silva Rudland S; Wilson JB; Aladwani A; Winstanley JH; Barraclough DL; Barraclough R; West CR; Jones NJ
Am J Pathol; 2010 Jun; 176(6):2935-47. PubMed ID: 20363922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
